Increased fetal blood pressure response to maternal norepinephrine after pharmacological inhibition of norepinephrine uptake in pregnant sheep.
OBJECTIVE
Norepinephrine (NE) is elevated in pregnancies complicated by preeclampsia (PE). Specific uptake of NE by the NE transporter (NET) plays a central role as regulator of NE levels. Expression of NET is reduced in placentas from PE pregnancies. To study adverse fetal effects of reduced NET expression on the placental buffering capacity, the NET was pharmacologically blocked by a specific uptake inhibitor reboxetine.


METHODS
We evaluated the effect of NE uptake inhibition on maternal and fetal arterial blood pressure responses to increasing maternal doses of NE in 10 chronically prepared fetal sheep. Arterial blood pressure was monitored continuously during increasing doses of i.v. NE.


RESULTS
NET inhibition increased both fetal and maternal mean arterial blood pressure (p < 0.001, respectively).


CONCLUSIONS
Reuptake by NET appears to be a mechanism protecting the fetus from NE. A reduced uptake capacity in preeclamptic pregnancies due to reduced NE uptake may lead to increased fetal arterial blood pressure.
Hansson
S R
SR
Obstetrics and Gynecology, Lund University, Lund, Sweden. stefan.hansson@med.lu.se
Bottalico
B
B
Amer-Wahlin
I
I
Marsál
K
K
Ley
D
D
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D005333:Fetus / Q000502:physiology*; D009025:Morpholines / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism* / Q000494:pharmacology*; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000187:drug effects*; D011247:Pregnancy; D000077593:Reboxetine; D012756:Sheep
D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D050484:Norepinephrine Plasma Membrane Transport Proteins; D000077593:Reboxetine; D009638:Norepinephrine